Figure 6
Figure 6. Bortezomib-induced polyubiquitination and Bax–ubiquitin conjugation. Fresh CLL cells were treated with bortezomib for 16 hours. (A) Polyubiquitination. CLL cells from 3 different patients were lysed with the lysis buffer. A total of 50 μg proteins was loaded into each lane. The antiubiquitin antibody was used at 1:500 dilution. Multiple ladders in the blot show an accumulation of polyubiquitinated proteins. (B) CLL cells were lysed with Chaps containing lysis buffer. A total of 500 μg protein was used for immunoprecipitation (IP) with Bax 6A7 antibody overnight at 4°C, and Bax–ubiquitin conjugation was probed with the antiubiquitin antibody at 1:500 dilution. The numbers on the left side of the blot are molecular weights of standard proteins. WB indicates Western blotting.

Bortezomib-induced polyubiquitination and Bax–ubiquitin conjugation. Fresh CLL cells were treated with bortezomib for 16 hours. (A) Polyubiquitination. CLL cells from 3 different patients were lysed with the lysis buffer. A total of 50 μg proteins was loaded into each lane. The antiubiquitin antibody was used at 1:500 dilution. Multiple ladders in the blot show an accumulation of polyubiquitinated proteins. (B) CLL cells were lysed with Chaps containing lysis buffer. A total of 500 μg protein was used for immunoprecipitation (IP) with Bax 6A7 antibody overnight at 4°C, and Bax–ubiquitin conjugation was probed with the antiubiquitin antibody at 1:500 dilution. The numbers on the left side of the blot are molecular weights of standard proteins. WB indicates Western blotting.

Close Modal

or Create an Account

Close Modal
Close Modal